Ina Research Incorporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ina Research Incorporation with three other
pharmaceutical manufacturers in Asia:
sales of 2.47 billion Japanese Yen [US$23.82 million]
of which 64%
was Health Inspection Equipment),
Hester Pharmaceuticals Limited
(1.01 billion Indian Rupees [US$15.07 million]
of which 91%
was Poultry Vaccines), and
Pharma Foods International Co.Ltd
(3.46 billion Japanese Yen [US$33.33 million]
Ina Research Incorporation reported sales of ¥2.12 billion (US$20.39 million)
March of 2016.
decrease of 29.3%
versus 2015, when the company's sales were ¥2.99 billion.
Contributing to the drop in overall sales was the 37.6% decline
in Non-Clinical Business, from ¥2.70 billion to ¥1.68 billion.
However, these declines were partially offset by the increase in sales of
Environmental Business (up 54.7% to ¥284.49 million)
Clinical Trial Business (up 30.8% to ¥149.26 million)